Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Peripheral Blood Stem Cell Transplantation in Advanced Hematologic Malignancies
NCT00544115Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Oct 2001
- Primary completion
- Mar 2007
01
Overview
A Phase 2 trial of allogeneic peripheral blood progenitor cells in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), myelodysplastic syndrome (MDS), non-Hodgkin lymphoma (NHL), sponsored by City of Hope. Started Oct 2001; status: active, not recruiting.
02
Drugs
allogeneic peripheral blood progenitor cells
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)chronic myelogenous leukemia (CML)myelodysplastic syndrome (MDS)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00544115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544115.